ABL Bio Inc. (KOSDAQ:298380)
190,600
-10,400 (-5.17%)
At close: Dec 5, 2025
566.43% (1Y)
| Market Cap | 10.51T |
| Revenue (ttm) | 88.44B |
| Net Income (ttm) | -28.65B |
| Shares Out | 55.13M |
| EPS (ttm) | -575.91 |
| PE Ratio | n/a |
| Forward PE | 949.41 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,635,907 |
| Average Volume | 1,827,381 |
| Open | 210,000 |
| Previous Close | 201,000 |
| Day's Range | 187,900 - 220,000 |
| 52-Week Range | 26,350 - 220,000 |
| Beta | 0.53 |
| RSI | 69.34 |
| Earnings Date | Nov 10, 2025 |